Advanced bioanalytical techniques for pharmacokinetic studies of nanocarrier drug delivery systems.
10.1016/j.jpha.2024.101070
- Author:
Xiangjun MENG
1
;
Jiayi YAO
1
;
Jingkai GU
2
Author Information
1. School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, 300072, China.
2. Research Center for Drug Metabolism, School of Life Sciences, Jilin University, Changchun, 130012, China.
- Publication Type:Review
- Keywords:
Bioanalysis;
Nanocarrier drug delivery systems;
Pharmacokinetics;
Sample fractionation technique
- From:
Journal of Pharmaceutical Analysis
2025;15(1):101070-101070
- CountryChina
- Language:English
-
Abstract:
Significant investment in nanocarrier drug delivery systems (Nano-DDSs) has yielded only a limited number of successfully marketed nanomedicines, highlighting a low rate of clinical translation. A primary contributing factor is the lack of foundational understanding of in vivo processes. Comprehensive knowledge of the pharmacokinetics of Nano-DDSs is essential for developing more efficacious nanomedicines and accurately evaluating their safety and associated risks. However, the complexity of Nano-DDSs has impeded thorough and systematic pharmacokinetic studies. Key components of pharmacokinetic investigations on Nano-DDSs include the analysis of the released drug, the encapsulated drug, and the nanomaterial, which present a higher level of complexity compared to traditional small-molecule drugs. Establishing an appropriate approach for monitoring the pharmacokinetics of Nano-DDSs is crucial for facilitating the clinical translation of nanomedicines. This review provides an overview of advanced bioanalytical methodologies employed in studying the pharmacokinetics of anticancer organic Nano-DDSs over the past five years. We hope that this review will enhance the understanding of the pharmacokinetics of Nano-DDSs and support the advancement of nanomedicines.
